Concepedia

Carlos Herrera

CH

4

Publications

228

Citations

4

H-Index

2000

Active since

Affiliations

Center of Molecular Immunology (Cuba)(Current)

Universidad Central "Marta Abreu" de las Villas (UCLV)

The University of Texas MD Anderson Cancer Center

Carlos Herrera is an author at Center of Molecular Immunology (Cuba) specializing in medicine, tumor biology, and vascular biology.

Top concepts

MedicineOncologyGynecologyImmunologyAngiogenesisTumor BiologyOvarian CancerVascular BiologyTumor MicroenvironmentCovid-19

Publications per year

2000–2021

4

Publications

4

Inhibition of malignant ascites and growth of human ovarian carcinoma by oral administration of a potent inhibitor of the vascular endothelial growth factor receptor tyrosine kinases.

Lei Xu, Junya Yoneda, Carlos Herrera et al. · International Journal of Oncology · 2000 · 149 citations

Potent Inhibitor, Human Ovarian Cancer, Gynecology +18

Expression of metastasis-related genes in human epithelial ovarian tumors

Carlos Herrera, Lu Xu, C D Bucana et al. · International Journal of Oncology · 2002 · 37 citations

Expression Level, Oncology, Angiogenesis +15

An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients

Danay Saavedra, Ana Laura Añé-Kourí, Naivy Sánchez et al. · Immunity & Ageing · 2020 · 30 citations · Full text

An Anti-CD6 Antibody for the Treatment of COVID-19 Patients with Cytokine-Release Syndrome: Report of Three Cases

Lázaro Manuel Filgueira, Julio Betancourt Cervantes, Orlando Adolfo Lovelle et al. · Immunotherapy · 2021 · 12 citations · Full text

Immunodeficiencies, Immunology, Immune Regulation +19

Rows per page

1–4 of 4